WM-3835

Catalog No.S9805 Batch:S980501

Print

Technical Data

Formula

C20H17FN2O4S

Molecular Weight 400.42 CAS No. 2229025-70-9
Solubility (25°C)* In vitro DMSO 80 mg/mL (199.79 mM)
Ethanol 80 mg/mL (199.79 mM)
Water Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
10% DMSO 40%PEG300 5%Tween80 45%ddH2O
9.0mg/ml Taking the 1 mL working solution as an example, add 100 μL of 90 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 450 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description WM-3835 is a novel and high-specific small molecule Lysine Acetyltransferase 7 (KAT7, MYST2, HBO1) inhibitor, able to potently suppressed OS cell proliferation and migration, and leads to apoptosis activation.
Targets
KAT7 [1]
In vitro

WM-3835 activates apoptosis while inhibites OS cell proliferation, migration and invasion. The activity of WM-3835 is nullified in HBO1-KO OS cells. Also, the HBO1 inhibitor is non-cytotoxic in HBO1-low human osteoblasts, which indicates that the anti-OS cell efficacy of WM-3835 is primarily through HBO1 inhibition.[1]

In vivo

In vivo, intraperitoneal injection of a single dose of WM-3835 potently inhibites OS xenograft growth in SCID mice.[1]

Protocol (from reference)

Cell Assay:

[1]

  • Cell lines

    Primary human OS cells (pOS-1 cells, pOS-2 cells)

  • Concentrations

    1 μM, 5 μM, 10 μM, 25 μM

  • Incubation Time

    24 h, 48 h, 72 h, 96 h

  • Method

    The pOS-1 cells are treated with WM-3835 or vehicle control (“Veh”, 0.5% DMSO), cells with treatments are seeded into 96-well plates at 3×103 cells per well. After 96 h incubation, in each well 10 μL CCK-8 reagent is added for 3 h. Later, CCK-8's OD value is recorded at 450 nm. Cell death is tested by Trypan blue staining using an automatic cell counter.

Animal Study:

[1]

  • Animal Models

    SCID mice

  • Dosages

    10 mg/kg

  • Administration

    IP

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.